Santen Pharmaceutical Co., Ltd. (TYO: 4536)
Japan
· Delayed Price · Currency is JPY 1,544.50
-4.50 (-0.29%)
Dec 20, 2024, 3:45 PM JST
Santen Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 19, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 529,171 | 559,190 | 424,342 | 490,898 | 608,810 | 742,066 | Upgrade
|
| Market Cap Growth | 20.30% | 31.78% | -13.56% | -19.37% | -17.96% | 12.77% | Upgrade
|
| Enterprise Value | 444,007 | 476,424 | 362,459 | 422,435 | 555,406 | 661,036 | Upgrade
|
| Last Close Price | 1544.50 | 1522.21 | 1094.42 | 1152.34 | 1398.45 | 1679.80 | Upgrade
|
| PE Ratio | 21.15 | 21.00 | - | 18.04 | 89.19 | 31.42 | Upgrade
|
| Forward PE | 14.88 | 17.09 | 25.03 | 16.25 | 21.32 | 20.43 | Upgrade
|
| PS Ratio | 1.82 | 1.85 | 1.52 | 1.84 | 2.44 | 3.07 | Upgrade
|
| PB Ratio | 1.87 | 1.83 | 1.45 | 1.46 | 1.98 | 2.45 | Upgrade
|
| P/TBV Ratio | 2.90 | 2.52 | 2.15 | 2.37 | 3.13 | 4.05 | Upgrade
|
| P/FCF Ratio | 8.03 | 8.83 | 21.36 | 17.11 | 17.56 | 21.75 | Upgrade
|
| P/OCF Ratio | 8.29 | 7.70 | 11.42 | 10.66 | 15.69 | 18.58 | Upgrade
|
| PEG Ratio | 2.47 | 2.79 | 2.79 | 2.79 | 3.56 | 3.88 | Upgrade
|
| EV/Sales Ratio | 1.47 | 1.58 | 1.30 | 1.59 | 2.23 | 2.74 | Upgrade
|
| EV/EBITDA Ratio | 7.02 | 6.77 | 6.90 | 7.98 | 7.90 | 11.71 | Upgrade
|
| EV/EBIT Ratio | 9.88 | 9.13 | 10.27 | 11.78 | 10.38 | 16.58 | Upgrade
|
| EV/FCF Ratio | 6.74 | 7.52 | 18.24 | 14.72 | 16.02 | 19.37 | Upgrade
|
| Debt / Equity Ratio | - | 0.11 | 0.12 | 0.10 | 0.03 | 0.04 | Upgrade
|
| Debt / EBITDA Ratio | - | 0.49 | 0.69 | 0.62 | 0.14 | 0.22 | Upgrade
|
| Debt / FCF Ratio | - | 0.55 | 1.82 | 1.15 | 0.29 | 0.36 | Upgrade
|
| Asset Turnover | 0.72 | 0.70 | 0.63 | 0.62 | 0.62 | 0.60 | Upgrade
|
| Inventory Turnover | 2.58 | 2.99 | 2.95 | 2.79 | 2.56 | 2.69 | Upgrade
|
| Quick Ratio | 1.85 | 1.99 | 1.84 | 1.91 | 2.02 | 2.64 | Upgrade
|
| Current Ratio | 2.61 | 2.54 | 2.38 | 2.39 | 2.63 | 3.23 | Upgrade
|
| Return on Equity (ROE) | 8.79% | 8.92% | -4.76% | 8.45% | 2.18% | 7.30% | Upgrade
|
| Return on Assets (ROA) | 7.62% | 7.61% | 5.01% | 5.20% | 8.25% | 6.23% | Upgrade
|
| Return on Capital (ROIC) | 10.71% | 9.74% | 6.31% | 6.53% | 10.58% | 8.15% | Upgrade
|
| Earnings Yield | 4.73% | 4.76% | -3.52% | 5.54% | 1.12% | 3.18% | Upgrade
|
| FCF Yield | 12.45% | 11.33% | 4.68% | 5.85% | 5.69% | 4.60% | Upgrade
|
| Dividend Yield | 2.20% | 2.17% | 2.92% | 2.78% | 2.00% | 1.61% | Upgrade
|
| Payout Ratio | 46.08% | 44.59% | - | 44.07% | 163.81% | 43.95% | Upgrade
|
| Buyback Yield / Dilution | 5.60% | 4.98% | 3.26% | -0.02% | -0.03% | 1.75% | Upgrade
|
| Total Shareholder Return | 7.80% | 7.14% | 6.18% | 2.76% | 1.97% | 3.36% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.